Elevance Health, one of the largest health insurers in the United States, has filed a lawsuit against the Centers for Medicare & Medicaid Services (CMS) alleging improper calculation of its Medicare Advantage star ratings, according to reporting by STAT News. The dispute centers on approximately $115 million in financial implications tied to how the federal agency assessed Elevance’s performance metrics.
Key takeaways
- Elevance Health is suing CMS over alleged miscalculation of Medicare Advantage star ratings worth approximately $115 million
- Star ratings directly affect insurer revenue, enrollment, and market competitiveness under federal payment models
- The case raises broader questions about transparency and methodology in how CMS evaluates health plan performance
- This reflects growing litigation over quality measurement standards in Medicare Advantage programs
What Medicare Advantage Star Ratings Measure
CMS assigns 1–5 star ratings across multiple performance domains; ratings directly determine plan bonuses and payment adjustments
Source: CMS Medicare Advantage Performance Data | Georgian Medical Journal News
The Financial Stakes of Star Ratings
Medicare Advantage star ratings represent far more than a quality label—they directly translate into revenue adjustments and bonus payments, according to CMS documentation on quality payment mechanisms. Insurers with higher star ratings receive bonus payments from the Centers for Medicare & Medicaid Services, while lower ratings can result in financial penalties and restrictions on enrollment.
Elevance’s challenge to its star rating calculation suggests the insurer believes CMS applied incorrect methodology in evaluating one or more performance domains. This aligns with a broader pattern of quality measurement disputes within the Medicare Advantage system, where methodological changes can reshape incentive structures across the insurance industry.
Methodology and Measurement Transparency
The core of Elevance’s lawsuit appears to hinge on how CMS calculated specific performance metrics, according to STAT News reporting. Star rating calculations involve dozens of individual measures—from medication adherence rates to member experience surveys—each weighted differently and aggregated into composite scores that determine final star assignments.
If CMS made an error in any of these computational steps, it could materially affect an insurer’s final rating and the associated bonus or penalty payments. This raises questions about the transparency and verifiability of CMS’s rating methodology, particularly given the high financial stakes involved. The evolving regulatory environment around quality metrics continues to be contested by industry players.
Elevance Health is seeking relief from what the company contends is an improper star rating calculation by the Centers for Medicare & Medicaid Services worth approximately $115 million in financial impact.
— Elevance Health litigation filing, per STAT News (July 2026)
Broader Implications for Medicare Advantage Quality Assessment
This lawsuit is not isolated. The Medicare Advantage market, which covers approximately 28 million beneficiaries according to CMS program statistics, has seen repeated disputes over quality measurement methodology. Insurance companies argue that CMS’s measurement approaches may not fairly reflect clinical performance or member outcomes, while regulators maintain that standardized ratings are essential for consumer choice and plan accountability.
The outcome of Elevance’s case could influence how CMS applies rating calculations across the entire Medicare Advantage industry, affecting payment distributions worth billions of dollars annually. It also underscores ongoing tensions in healthcare quality measurement between standardized federal approaches and the complexity of real-world clinical performance.
What this means
Frequently asked questions
What are Medicare Advantage star ratings?
Star ratings are CMS’s annual quality assessment of Medicare Advantage plans, rated from 1 to 5 stars based on dozens of clinical and operational performance measures. Plans with higher ratings receive bonus payments, while lower-rated plans may face enrollment restrictions, according to CMS quality payment guidelines.
How much money does a star rating difference represent?
CMS calculates bonus payments—sometimes called quality bonuses or quality improvement bonuses—that can amount to tens or hundreds of millions of dollars for large national insurers. Elevance’s $115 million dispute illustrates the scale of financial impact at stake, per STAT News.
Why would an insurer challenge its star rating?
Insurers may challenge ratings if they believe CMS applied an incorrect formula, used inaccurate data, or weighted performance measures inappropriately. Since ratings directly determine revenue, even small methodological errors can result in millions of dollars in payment adjustments.
As the Medicare Advantage program continues to expand—now covering more than one-quarter of all Medicare beneficiaries—the standards by which plans are measured and compared become increasingly consequential. The Elevance case signals that insurers will continue to scrutinize CMS methodology, and that greater transparency and standardization may be necessary to resolve future disputes.
Source: STAT News — Elevance sues government over $115 million tied to Medicare Advantage star ratings
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
